Marshall Wace
HIMS icon

Marshall Wace’s Hims & Hers Health HIMS Stock Holding History

Marshall Wace’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-352,300
Closed -$8.52M – 2816
2024
Q4 		$8.52M Buy
+352,300
New +$8.73M 0.01% 852

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DE
Defiance ETFs New York $6.98B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Marshall Wace's HIMS Position: Q1 2026 in Review

Marshall Wace increased its Hims & Hers Health (HIMS) stake by 11,399% in Q1 2026, buying an estimated $17M and bringing the position to 724,227 shares worth $15M. The position accounts for 0.02% of the portfolio, ranked #803.

Marshall Wace first reported a position in HIMS in Q4 2019 and has held it in 23 quarters since. The position peaked at $87.3M in Q1 2024. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Marshall Wace held 724,227 shares of Hims & Hers Health worth $15M as of Q1 2026.
  • Marshall Wace bought 717,929 Hims & Hers Health shares in Q1 2026, an estimated $17M.
  • Hims & Hers Health made up 0.02% of Marshall Wace's portfolio in Q1 2026, its #803 holding.
  • Marshall Wace first reported a position in Hims & Hers Health in Q4 2019 and has held it in 23 quarters since.
  • Marshall Wace's Hims & Hers Health position peaked at $87.3M in Q1 2024.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.